The purpose of this study is to determine whether doxorubicin hydrochloride liposome is
superior to doxorubicin when combined with bortizomib and dexamethasone for treating patient
with initially diagnosed multiple myeloma.
Phase:
Phase 4
Details
Lead Sponsor:
The First Affiliated Hospital of Soochow University